South Korea
· Delayed Price · Currency is KRW MegaMD Statistics
Total Valuation
MegaMD has a market cap or net worth of KRW 46.03 billion. The enterprise value is 5.11 billion.
| Market Cap | 46.03B |
| Enterprise Value | 5.11B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MegaMD has 22.07 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 22.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 4.23% |
| Float | 10.55M |
Valuation Ratios
The trailing PE ratio is 21.34.
| PE Ratio | 21.34 |
| Forward PE | n/a |
| PS Ratio | 1.28 |
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | 5.34 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 0.80, with an EV/FCF ratio of 0.59.
| EV / Earnings | 2.37 |
| EV / Sales | 0.14 |
| EV / EBITDA | 0.80 |
| EV / EBIT | 4.04 |
| EV / FCF | 0.59 |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.67 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.52 |
| Debt / FCF | 0.42 |
| Interest Coverage | 7.11 |
Financial Efficiency
Return on equity (ROE) is 3.33% and return on invested capital (ROIC) is 1.66%.
| Return on Equity (ROE) | 3.33% |
| Return on Assets (ROA) | 1.34% |
| Return on Capital (ROIC) | 1.66% |
| Revenue Per Employee | 231.34M |
| Profits Per Employee | 13.83M |
| Employee Count | 156 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 31.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.06% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -21.06% |
| 50-Day Moving Average | 2,046.40 |
| 200-Day Moving Average | 2,288.55 |
| Relative Strength Index (RSI) | 49.60 |
| Average Volume (20 Days) | 407,767 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MegaMD had revenue of KRW 36.09 billion and earned 2.16 billion in profits. Earnings per share was 97.72.
| Revenue | 36.09B |
| Gross Profit | 21.34B |
| Operating Income | 1.84B |
| Pretax Income | 2.94B |
| Net Income | 2.16B |
| EBITDA | 6.96B |
| EBIT | 1.84B |
| Earnings Per Share (EPS) | 97.72 |
Balance Sheet
The company has 44.54 billion in cash and 3.62 billion in debt, giving a net cash position of 40.92 billion or 1,853.62 per share.
| Cash & Cash Equivalents | 44.54B |
| Total Debt | 3.62B |
| Net Cash | 40.92B |
| Net Cash Per Share | 1,853.62 |
| Equity (Book Value) | 65.64B |
| Book Value Per Share | 2,973.62 |
| Working Capital | 29.21B |
Cash Flow
In the last 12 months, operating cash flow was 8.69 billion and capital expenditures -80.68 million, giving a free cash flow of 8.61 billion.
| Operating Cash Flow | 8.69B |
| Capital Expenditures | -80.68M |
| Free Cash Flow | 8.61B |
| FCF Per Share | 390.12 |
Margins
Gross margin is 59.14%, with operating and profit margins of 5.09% and 5.98%.
| Gross Margin | 59.14% |
| Operating Margin | 5.09% |
| Pretax Margin | 8.14% |
| Profit Margin | 5.98% |
| EBITDA Margin | 19.28% |
| EBIT Margin | 5.09% |
| FCF Margin | 23.86% |
Dividends & Yields
MegaMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.69% |
| FCF Yield | 18.71% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MegaMD has an Altman Z-Score of 3.2.
| Altman Z-Score | 3.2 |
| Piotroski F-Score | n/a |